113 related articles for article (PubMed ID: 34957975)
1. Effects of in vitro short- and long-term treatment with telomerase inhibitor in U-251 glioma cells.
Andrade da Mota TH; Reis Guimarães AF; Silva de Carvalho AÉ; Saldanha-de Araujo F; Pinto de Faria Lopes G; Pittella-Silva F; do Amaral Rabello D; Madureira de Oliveira D
Tumour Biol; 2021; 43(1):327-340. PubMed ID: 34957975
[TBL] [Abstract][Full Text] [Related]
2. Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells.
Morais KDS; Arcanjo DDS; de Faria Lopes GP; da Silva GG; da Mota THA; Gabriel TR; Rabello Ramos DDA; Silva FP; de Oliveira DM
Cell Biochem Funct; 2019 Jun; 37(4):273-280. PubMed ID: 31012504
[TBL] [Abstract][Full Text] [Related]
3. Targeting DNA-PKcs and telomerase in brain tumour cells.
Gurung RL; Lim HK; Venkatesan S; Lee PS; Hande MP
Mol Cancer; 2014 Oct; 13():232. PubMed ID: 25307264
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X
Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693
[TBL] [Abstract][Full Text] [Related]
5. Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic, proliferative and inflammatory genes.
Ameri Z; Ghiasi S; Farsinejad A; Hassanshahi G; Ehsan M; Fatemi A
Life Sci; 2019 Jul; 228():66-71. PubMed ID: 31029779
[TBL] [Abstract][Full Text] [Related]
6. MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells.
Gurung RL; Lim SN; Low GK; Hande MP
J Nutrigenet Nutrigenomics; 2014; 7(4-6):283-98. PubMed ID: 26022559
[TBL] [Abstract][Full Text] [Related]
7. Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells.
Celeghin A; Giunco S; Freguja R; Zangrossi M; Nalio S; Dolcetti R; De Rossi A
Cell Death Dis; 2016 Dec; 7(12):e2562. PubMed ID: 28032863
[TBL] [Abstract][Full Text] [Related]
8. MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-κB pathway.
Fatemi A; Safa M; Kazemi A
Tumour Biol; 2015 Nov; 36(11):8425-37. PubMed ID: 26022158
[TBL] [Abstract][Full Text] [Related]
9. Berberine Inhibits Telomerase Activity and Induces Cell Cycle Arrest and Telomere Erosion in Colorectal Cancer Cell Line, HCT 116.
Samad MA; Saiman MZ; Abdul Majid N; Karsani SA; Yaacob JS
Molecules; 2021 Jan; 26(2):. PubMed ID: 33450878
[TBL] [Abstract][Full Text] [Related]
10. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Liu W; Yin Y; Wang J; Shi B; Zhang L; Qian D; Li C; Zhang H; Wang S; Zhu J; Gao L; Zhang Q; Jia B; Hao L; Wang C; Zhang B
Oncotarget; 2017 Jan; 8(1):179-190. PubMed ID: 27329725
[TBL] [Abstract][Full Text] [Related]
11. Long-term exposure to MST-312 leads to telomerase reverse transcriptase overexpression in MCF-7 breast cancer cells.
Morais KS; Guimarãesb AFR; Ramos DAR; Silva FP; de Oliveira DM
Anticancer Drugs; 2017 Aug; 28(7):750-756. PubMed ID: 28520570
[TBL] [Abstract][Full Text] [Related]
12. Dracorhodin perchlorate induces the apoptosis of glioma cells.
Chen X; Luo J; Meng L; Pan T; Zhao B; Tang ZG; Dai Y
Oncol Rep; 2016 Apr; 35(4):2364-72. PubMed ID: 26846469
[TBL] [Abstract][Full Text] [Related]
13. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
[TBL] [Abstract][Full Text] [Related]
14. Targeting telomerase with radiolabeled inhibitors.
Waghorn PA; Jackson MR; Gouverneur V; Vallis KA
Eur J Med Chem; 2017 Jan; 125():117-129. PubMed ID: 27657809
[TBL] [Abstract][Full Text] [Related]
15. Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
Sengupta S; Sobo M; Lee K; Senthil Kumar S; White AR; Mender I; Fuller C; Chow LML; Fouladi M; Shay JW; Drissi R
Mol Cancer Ther; 2018 Jul; 17(7):1504-1514. PubMed ID: 29654065
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibition as a novel therapy for pediatric ependymoma.
Wong VC; Morrison A; Tabori U; Hawkins CE
Brain Pathol; 2010 Jul; 20(4):780-6. PubMed ID: 20184588
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
Li G; Shen J; Cao J; Zhou G; Lei T; Sun Y; Gao H; Ding Y; Xu W; Zhan Z; Chen Y; Huang H
J Exp Clin Cancer Res; 2018 Apr; 37(1):78. PubMed ID: 29631594
[TBL] [Abstract][Full Text] [Related]
20. Genistein induces growth arrest and suppresses telomerase activity in brain tumor cells.
Khaw AK; Yong JW; Kalthur G; Hande MP
Genes Chromosomes Cancer; 2012 Oct; 51(10):961-74. PubMed ID: 22736505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]